EMBRACE, eribulin, and new realities of advanced breast cancer.
Saved in:
| Title: | EMBRACE, eribulin, and new realities of advanced breast cancer. |
|---|---|
| Authors: | Lin, Nancy U. (AUTHOR), Burstein, Harold J. (AUTHOR) |
| Source: | Lancet. 3/12/2011, Vol. 377 Issue 9769, p878-880. 3p. |
| Subjects: | Breast cancer research, Breast cancer patients, Breast cancer treatment, Quality of life, Drug therapy |
| Abstract: | In this article the authors discuss the Epidemiological Study of Familial Breast Cancer (EMBRACE) study and facts regarding advanced breast cancer. The authors say that EMBRACE study is a phase three study which compares eribulin or treatment of physician's choice (TPC) for advanced breast cancer. They argue that the EMBRACE study shows that chemotherapy of breast cancer is improving and enhances the quality of life of cancer patients. |
| Database: | Psychology and Behavioral Sciences Collection |
Be the first to leave a comment!
